The first link between the Hh signaling pathway and cancer originated from the discovery of PTCH mutations in basal cell nevus syndrome (BCNS, also known as Gorlin syndrome or nevoid BCC syndrome [54,55]), a rare and hereditary form of BCC [56,57]. The gene discussed is PTCH1; the disease is nevoid basal cell carcinoma syndrome.